Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1997
11/18/1997US5688518 Antidepressive therapy
11/18/1997US5688500 Method of aquaculture comprising feeding microflora having a small cell aggregate size
11/18/1997US5688499 Antagonism of endothelin actions
11/18/1997US5688495 Acetylsalicylic acid, solvent mixture of propylene glycol and glycerol with alcohol
11/18/1997US5688486 Use of fullerenes in diagnostic and/or therapeutic agents
11/18/1997CA2122705C Optically active 1-phenylpyrrolidone derivative, intermediate for producing the same, and process for producing both
11/18/1997CA2122360C Quinazolinone antianginal agents
11/18/1997CA2049160C Water soluble derivatives of taxol
11/18/1997CA2048355C P-oxybenzoic acid derivatives, process for the preparation thereof and use thereof as drug
11/15/1997CA2205477A1 Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/13/1997WO1997042329A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
11/13/1997WO1997042325A1 B. burgdorferi polypeptides expressed in vivo
11/13/1997WO1997042324A1 Use of interleukin-10 to produce a population of suppressor cells
11/13/1997WO1997042322A1 Glycoprotein hormone superagonists
11/13/1997WO1997042224A1 Neurotactin and uses therefor
11/13/1997WO1997042222A1 Methods and means for inhibition of cdk4 activity
11/13/1997WO1997042219A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR
11/13/1997WO1997042218A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
11/13/1997WO1997042214A1 Androstene derivatives
11/13/1997WO1997042213A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
11/13/1997WO1997042211A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor
11/13/1997WO1997042205A1 3-descladinose-2,3-anhydroerythromycin derivatives
11/13/1997WO1997042204A1 6-o-substituted erythromycins and method for making them
11/13/1997WO1997042195A1 Process for the preparation of an indacene compound
11/13/1997WO1997042191A1 Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
11/13/1997WO1997042190A1 Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
11/13/1997WO1997042187A1 Oxindole derivatives
11/13/1997WO1997042184A1 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen fumarate
11/13/1997WO1997042183A1 Benzofuryl derivatives and their use
11/13/1997WO1997042179A1 Antibacterial agents
11/13/1997WO1997042175A1 Substituted imidazolium salts and their use for the inhibition of protein ageing
11/13/1997WO1997042174A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
11/13/1997WO1997042156A1 Anti-viral compounds
11/13/1997WO1997042155A1 Anti-viral compounds
11/13/1997WO1997042154A1 Anti-viral compounds
11/13/1997WO1997042152A1 Vitamin d analogs and methods of preparing these compounds
11/13/1997WO1997041899A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides
11/13/1997WO1997041898A1 Targeted combination immunotherapy of cancer
11/13/1997WO1997041897A1 Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones
11/13/1997WO1997041896A2 Inclusion complexes of aryl-heterocyclic salts
11/13/1997WO1997041895A2 TREATMENT OF ASTHMA WITH TNFR-Ig
11/13/1997WO1997041893A1 Composition containing a nerve fibre reactivity modulating compound
11/13/1997WO1997041889A1 Feline vaccines containing chlamydia psittaci and method for making the same
11/13/1997WO1997041886A1 Stimulation of host defence mechanisms against tumors
11/13/1997WO1997041883A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997WO1997041882A1 Method for treating inflammation
11/13/1997WO1997041881A1 Morphogen treatment for chronic renal failure
11/13/1997WO1997041880A1 Therapies for chronic renal failure
11/13/1997WO1997041879A1 Enhancement of sleep with a growth hormone secretagogue
11/13/1997WO1997041878A1 Treatment of mood disorders with a growth hormone secretagogue
11/13/1997WO1997041875A1 Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
11/13/1997WO1997041874A1 Phosphatidic acid-comprising compositions
11/13/1997WO1997041873A1 Method and composition for the treatment of lipid and glucose metabolism disorders
11/13/1997WO1997041872A1 Oral contraceptive
11/13/1997WO1997041871A1 Oral contraceptive
11/13/1997WO1997041870A1 Oral contraceptive
11/13/1997WO1997041869A1 Oral contraceptive
11/13/1997WO1997041868A1 Oral contraceptive
11/13/1997WO1997041867A1 Use of steroid compounds to prevent non-cancerous tissue growth
11/13/1997WO1997041866A1 Improvement of implantation rates after in vitro fertilization
11/13/1997WO1997041865A1 Topical penile androgen application for treatment of erectile dysfunction
11/13/1997WO1997041864A1 Ophthalmic preparations
11/13/1997WO1997041863A1 Mixed chimerism and tolerance
11/13/1997WO1997041862A1 Use of aspirochlorine or derivatives thereof as immunosuppressive agents
11/13/1997WO1997041861A1 Anti-viral compounds
11/13/1997WO1997041860A1 Anti-viral compounds
11/13/1997WO1997041859A1 Use of panaverium bromide for preventing cell proliferation and diseases caused thereby in the liver and digestive tract
11/13/1997WO1997041858A1 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
11/13/1997WO1997041857A1 Composition comprising a katp channel inhibitor for use in the treatment of hemorrhagic shock
11/13/1997WO1997041855A1 Method for treating viral infections
11/13/1997WO1997041854A1 Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same
11/13/1997WO1997041853A1 Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient
11/13/1997WO1997041852A1 Angiostatic compounds
11/13/1997WO1997041851A1 Benzothiophenes, formulations containing same, and methods
11/13/1997WO1997041850A1 Paclitaxel for the treatment of rheumatic diseases
11/13/1997WO1997041849A1 Anti-viral method
11/13/1997WO1997041848A1 Pharmaceutical compositions containing alpha-keto carboxylates
11/13/1997WO1997041847A1 Antioxidant compounds
11/13/1997WO1997041846A1 Anti-viral compounds
11/13/1997WO1997041845A2 Use of fatty alcohol ethers for the inhibition of neurodegenerative diseases
11/13/1997WO1997041844A1 Combinations of angiostatic compounds
11/13/1997WO1997041839A1 Taste masked liquid suspensions
11/13/1997WO1997041837A2 Microparticles
11/13/1997WO1997041834A1 Cationic virosomes as transfer system for genetic material
11/13/1997WO1997041833A1 Dispersible macromolecule compositions and methods for their preparation and use
11/13/1997WO1997041832A1 Suspension of sparingly water-soluble acidic drug
11/13/1997WO1997041831A1 Stimulation of immune response with low doses of il-2
11/13/1997WO1997041830A1 Reparation and prevention of fibrotic lesions
11/13/1997WO1997041826A1 Use of tempol in the prevention of photoaging
11/13/1997WO1997041822A2 Anti-viral compounds
11/13/1997WO1997037998A3 Neuropeptide y receptor y5 and nucleic acid sequence
11/13/1997WO1997032607A3 Activated linkers and methods for making and purifying the same
11/13/1997WO1997031655A3 Modified cytokines for therapeutic use
11/13/1997WO1997031611A3 Treatment of begnin prostatic hyperplasia
11/13/1997WO1997029195A3 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
11/13/1997WO1997027177A3 Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists
11/13/1997WO1997025032A3 Monoglyceride compositions and their use against helicobacter
11/13/1997WO1997024116A3 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
11/13/1997WO1996040048A3 Novel uses for thyroid hormones or thyroid hormone-like compounds
11/13/1997DE19619036A1 Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with carbo- or heterocyclic substituent at C-25, process for their preparation and the use thereof for producing medicaments
1 ... 6724 6725 6726 6727 6728 6729 6730 6731 6732 6733 6734 6735 6736 6737 6738 6739 6740 6741 6742 6743 6744 ... 7860